Laboratory Corporation of...

229.00
7.54 (3.40%)
At close: Apr 14, 2025, 3:06 PM
3.40%
Bid 228.89
Market Cap 19.16B
Revenue (ttm) 13.01B
Net Income (ttm) 746M
EPS (ttm) 8.84
PE Ratio (ttm) 25.9
Forward PE 15.56
Analyst Buy
Ask 229.11
Volume 455,368
Avg. Volume (20D) 707,095
Open 223.67
Previous Close 221.46
Day's Range 223.32 - 229.33
52-Week Range 191.97 - 258.59
Beta 0.97

About LH

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin ...

Sector Healthcare
IPO Date Mar 29, 1990
Employees 60,900
Stock Exchange NYSE
Ticker Symbol LH
Full Company Profile

Analyst Forecast

According to 19 analyst ratings, the average rating for LH stock is "Buy." The 12-month stock price forecast is $267.5, which is an increase of 16.81% from the latest price.

Stock Forecasts

Next Earnings Release

Laboratory Corporation of America is scheduled to release its earnings on Apr 29, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+4.62%
Labcorp Holdings shares are trading higher after t... Unlock content with Pro Subscription
8 months ago
+8.33%
Labcorp shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates.